Dolby Laboratories Inc

For the period ended Dec 27, 2024. Filed Jan 30, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 27, 2024 · Filed Jan 30, 2025

DLB$64.67-0.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Unaudited Interim Condensed Consolidated Balance Sheets

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

	December 27,2024	September 27,2024
ASSETS
Current assets:
Cash and cash equivalents	$520,821	$482,047
Restricted cash	90,836	95,705
Accounts receivable, net of allowance for credit losses of $5,892 and $5,361	339,304	315,465
Contract assets, net of allowance for credit losses of $107 and $106	220,892	197,478
Inventories, net	31,833	33,728
Prepaid expenses and other current assets	82,113	69,994
Total current assets	1,285,799	1,194,417
Long-term investments	86,304	89,267
Property, plant, and equipment, net	476,113	479,109
Operating lease right-of-use assets	36,972	39,046
Intangible assets, net	421,242	434,514
Goodwill	520,419	533,208
Deferred taxes	227,021	219,758
Other non-current assets	104,732	120,609
Total assets	$3,158,602	$3,109,928
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$11,550	$17,380
Accrued liabilities	360,915	347,529
Income taxes payable	20,875	9,045
Contract liabilities	37,111	31,644
Operating lease liabilities	11,426	12,238
Total current liabilities	441,877	417,836
Non-current contract liabilities	32,481	34,593
Non-current operating lease liabilities	33,019	34,754
Other non-current liabilities	134,197	135,852
Total liabilities	641,574	623,035
Commitment and Contingencies (See Note 15)
Stockholders’ equity:
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 61,193,222 shares issued and outstanding as of December 27, 2024 and 59,722,442 as of September 27, 2024	55	53
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 35,170,779 shares issued and outstanding as of December 27, 2024 and 35,670,779 as of September 27, 2024	40	41
Retained earnings	2,543,413	2,496,255
Accumulated other comprehensive loss	(35,542)	(19,187)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,507,966	2,477,162
Noncontrolling interest	9,062	9,731
Total stockholders’ equity	2,517,028	2,486,893
Total liabilities and stockholders’ equity	$3,158,602	$3,109,928

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.